Literature DB >> 22898711

Abnormal glucose metabolism is associated with reduced left ventricular contractile reserve and exercise intolerance in patients with chronic heart failure.

M Egstrup1, C N Kistorp, M Schou, D E Høfsten, J E Møller, C D Tuxen, I Gustafsson.   

Abstract

AIMS: To investigate the associations between glucose metabolism, left ventricular (LV) contractile reserve, and exercise capacity in patients with chronic systolic heart failure (HF). METHODS AND
RESULTS: From an outpatient HF clinic, 161 patients with systolic HF were included (mean age 70 ± 10 years, 69% male, 59% had ischaemic heart disease, mean LV ejection fraction (LVEF) 37 ± 9%). Thirty-four (21%) patients had known diabetes mellitus (DM). Oral glucose tolerance testing (OGTT) classified patients without a prior DM diagnosis as normal glucose tolerance (NGT), impaired glucose tolerance or new DM. All patients completed low-dose dobutamine echocardiography (LDDE) and 154 patients a 6-min walking distance test (6MWD). Compared with patients with NGT, patients with known DM had lower resting LVEF (33.4 vs. 39.1%, P < 0.05) and higher E/e' (13.9 vs. 11.4, P < 0.05). During LDDE, an increase in LVEF could be observed in all glycemic groups (mean 8.2% absolute increase), but the contractile reserve was lower in patients with known DM (-5.4%, P = 0.001) and new DM (-3.5%, P = 0.035) compared to patients with NGT. 6MWD was lower in known DM (349 m) and new DM (379 m) compared with NGT (467 m) (P < 0.001). Differences in clinical variables, resting echocardiographic parameters or contractile reserve, did not explain the exercise intolerance related to diabetes.
CONCLUSION: Diabetes, known or newly detected by OGTT, is independently associated with reduced LV contractile reserve and exercise intolerance in outpatients with systolic HF. These findings may offer one explanation for the excess mortality related to diabetes in HF.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22898711     DOI: 10.1093/ehjci/jes165

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  6 in total

Review 1.  Cardiogenic diabetes.

Authors:  Maya Guglin; Arnaldo Villafranca; Anthony Morrison
Journal:  Heart Fail Rev       Date:  2014-09       Impact factor: 4.214

2.  Contributions of Comorbid Diabetes to Sleep Characteristics, Daytime Symptoms, and Physical Function Among Patients With Stable Heart Failure.

Authors:  Cynthia Fritschi; Nancy S Redeker
Journal:  J Cardiovasc Nurs       Date:  2015 Sep-Oct       Impact factor: 2.083

Review 3.  Consensus document: management of heart failure in type 2 diabetes mellitus.

Authors:  Upendra Kaul; Saumitra Ray; D Prabhakar; Arun Kochar; Kamal Sharma; Prakash Kumar Hazra; Subhash Chandra; Dharmesh Ramakant Bhai Solanki; Anjan Lal Dutta; Viveka Kumar; M Srinivas Rao; Abraham Oomman; Sameer Dani; Brian Pinto; T R Raghu
Journal:  Heart Fail Rev       Date:  2021-09       Impact factor: 4.214

4.  Galectin-3 and fibulin-1 in systolic heart failure - relation to glucose metabolism and left ventricular contractile reserve.

Authors:  Pernille Holmager; Michael Egstrup; Ida Gustafsson; Morten Schou; Jordi S Dahl; Lars Melholt Rasmussen; Jacob E Møller; Christian Tuxen; Jens Faber; Caroline Kistorp
Journal:  BMC Cardiovasc Disord       Date:  2017-01-10       Impact factor: 2.298

5.  Targeting the DPP-4-GLP-1 pathway improves exercise tolerance in heart failure patients: a systematic review and meta-analysis.

Authors:  Chengcong Chen; Ying Huang; Yongmei Zeng; Xiyan Lu; Guoqing Dong
Journal:  BMC Cardiovasc Disord       Date:  2019-12-23       Impact factor: 2.298

6.  Admission Glucose Levels and Associated Risk for Heart Failure After Myocardial Infarction in Patients Without Diabetes.

Authors:  Viveca Ritsinger; Emil Hagström; Bo Lagerqvist; Anna Norhammar
Journal:  J Am Heart Assoc       Date:  2021-10-30       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.